Zeitschrift für Gastroenterologie, Table of Contents Z Gastroenterol 2001; 39(1): 39-42DOI: 10.1055/s-2001-10697 Leitlinien der DGVS© Karl Demeter Verlag im Georg Thieme Verlag Stuttgart · New YorkFulminanter SchubE. F. Stange Stuttgart Recommend Article Abstract Buy Article Full Text References Literatur 1 Hyde G M, Jewell D P. Review article: The management of severe ulcerative colitis. Aliment Pharmacol Ther. 1997; 11 419-424 (IV) 2 Marion J F, Present D H. The modern medical management of acute severe colitis. Eur J Gastroenterol Hepatol. 1997; 9 831-835 (IV) 3 Truelove S C, Witts LJ. Cortisone in ulcerative colitis. BMJ. 1955; 2 1041-1048 (II b) 4 Meyers S, Lerer P K, Feuer E J. et al . Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol. 1987; 9 50-54 (I b) 5 Travis S P, Farrant J M, Ricketts C. et al . Predicting outcome in severe ulcerative colitis. Gut. 1996; 38 905-910 (III) 6 Buckell N A, Lennard J J, Hernandez M A. et al . Measurement of serum proteins during attacks of ulcerative colitis as a guide to patient management. Gut. 1979; 20 22-27 (III) 7 Powell T J, Day D W, Buckell N A. et al . Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci. 1982; 27 533-537 (III) 8 Chew C N, Nolan D J, Jewell D P. Small bowel gas in severe ulcerative colitis. Gut. 1991; 32 1535-1537 (III) 9 Almer S, Bodemar G, Franzen L. et al . Use of air enema radiography to assess depth of ulceration during acute attacks of ulcerative colitis. Lancet. 1996; 347 1731-1735 (III) 10 Lichtiger S, Present D H, Kornbluth A. et al . Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994; 330 1841-1845 (I b) 11 Meyers S, Sachar D B, Goldberg J D. et al . Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. Gastroenterology. 1983; 85 351-357 (I b) 12 Jarnerot G, Rolny P, Sandberg G H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology. 1985; 89 1005-1013 (II b) 13 Truelove S C, Willoughby C P, Lee E G. et al . Further experience in the treatment of severe attacks of ulcerative colitis. Lancet. 1978; 2 1086-1088 (II b) 14 Kjeldsen J. Treatment of ulcerative colitis with high doses of oral prednisolone. The rate of remission, the need for surgery, and the effect of prolonging the treatment. Scand J Gastroenterol. 1993; 28 821-826 (II b) 15 McIntyre P B, Powell T J, Wood S R. et al . Controlled trial of bowel rest in the treatment of severe acute colitis. Gut. 1986; 27 481-485 (I b) 16 Dickinson R J, Ashton M G, Axon A T. et al . Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology. 1980; 79 1199-1204 (I b) 17 Gonzalez H F, Fernandez B F, Esteve C M. et al . Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol. 1993; 88 227-232 (I b) 18 Seo M, Okada M, Yao T. et al . The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease. J Clin Gastroenterol. 1999; 29 270-275 (II b) 19 Chapman R W, Selby W S, Jewell D P. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut. 1986; 27 1210-1212 (I b) 20 Dickinson R J, O’Connor H J, Pinder I. et al . Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut. 1985; 26 1380-1384 (I b) 21 Mantzaris G J, Hatzis A, Kontogiannis P. et al . Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. Am J Gastroenterol. 1994; 89 43-46 (I b) 22 Carbonnel F, Boruchowicz A, Duclos B. et al . Intravenous cyclosporine in attacks of ulcerative colitis: Short-term and long-term responses. Dig Dis Sci. 1996; 41 2471-2476 (II b) 23 Wenzl H H, Petritsch W, Aichbichler B W. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis. Z Gastroenterol. 1998; 36 287-293 (II b) 24 Stack W A, Long R G, Hawkey C J. Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther. 1998; 12 973-978 (II b) 25 Cohen R D, Stein R, Hanauer S B. Intravenous cyclosporin in ulcerative colitis: A five-year experience. Am J Gastroenterol. 1999; 94 1587-1592 (II b) 26 Fellermann K, Ludwig D, Stahl M. et al . Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus (FK506). Am J Gastroenterol. 1998; 93 1860-1866 (II b) 27 Actis G C, Aimo G, Priolo G. et al . Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin cyclosporin in the treatment of severe steroid refractory ulcerative colitis: An open-label retrospective trial. Inflamm Bowel Dis. 1998; 4 276-279 (II b) 28 Fernandez-Banares F, Bertran X, Esteve C M. et al . Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis. Am J Gastroenterol. 1996; 91 2498-2499 (II b) 29 Treem W R, Davis P M, Hyams J S. Cyclosporine treatment of severe ulcerative colitis in children. J Pediatr. 1991; 119 994-997 (II b) 30 Kader H A, Mascarenhas M R, Piccoli D A. et al . Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. J Pediatr Gastroenterol Nutr. 1999; 28 54-58 (II b) 31 Folwacny C, Wiebecke B, Loeschke K. Unfractionated heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol. 1999; 94 1551-1555 (II b) 32 Evans R C, Wong V S, Morris A I. et al . Treatment of corticosteroid-resistant ulcerative colitis with heparin - a report of 16 cases. Aliment Pharmacol Ther. 1997; 11 1037-1040 (II b)
